Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, weight loss drugs
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries
A new warning from the FDA for GLP1 drugs including Ozempic and Wegovy
In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia– but for patients, on gGLP-1's there may still be gastric juices, in the stomach, since the drugs slow down the process of emptying the stomach.
Fortune on MSN
2d
RFK Jr. is expected to join Trump’s government after warning the ‘FDA’s war on public health is about to end,’ telling all employees to ‘pack your bags’
Kennedy Jr. has been a vaccine skeptic, sometimes a conspiracy theorist, and he might just be a part of president-elect ...
Medpage Today on MSN
1d
FDA Adds New Warning to GLP-1 Drugs
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Labels of all GLP-1 receptor agonists now carry ...
2d
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
2d
on MSN
FDA says commonly used decongestant 'not effective,' proposes removal
The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its ...
STAT
6d
Pharmalittle: We’re reading about a weight loss pill, the FDA warning a compounder, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...
2d
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
2d
on MSN
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...
Food Safety News
6d
FDA issues warning letters to mushroom and produce importers for critical safety violations
Some letters are not posted for public view until weeks or months after they are sent. Business owners have 15 days to respond to
FDA warning
letters.
Warning
letters often are not issued until a ...
Endocrinology Advisor
2d
FDA Issues Safety Alert for Compounded Drugs Distributed by CA Facility
The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback